This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jul 1;184(1):4-5.

doi: 10.1164/rccm.201105-0813ED.

End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis

Paul W Noble, Luca Richeldi, Naftali Kaminski

PMID: 21737589
DOI: 10.1164/rccm.201105-0813ED

Editorial

End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis

Paul W Noble et al. Am J Respir Crit Care Med. 2011.

. 2011 Jul 1;184(1):4-5.

doi: 10.1164/rccm.201105-0813ED.

Authors

Paul W Noble, Luca Richeldi, Naftali Kaminski

PMID: 21737589
DOI: 10.1164/rccm.201105-0813ED

No abstract available

PubMed Disclaimer

Comment on

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
King TE Jr, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J. King TE Jr, et al. Am J Respir Crit Care Med. 2011 Jul 1;184(1):92-9. doi: 10.1164/rccm.201011-1874OC. Epub 2011 Apr 7. Am J Respir Crit Care Med. 2011. PMID: 21474646 Clinical Trial.

Similar articles

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
King TE Jr, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J. King TE Jr, et al. Am J Respir Crit Care Med. 2011 Jul 1;184(1):92-9. doi: 10.1164/rccm.201011-1874OC. Epub 2011 Apr 7. Am J Respir Crit Care Med. 2011. PMID: 21474646 Clinical Trial.
Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.
Varga J. Varga J. Curr Rheumatol Rep. 2003 Apr;5(2):145-6. doi: 10.1007/s11926-003-0042-4. Curr Rheumatol Rep. 2003. PMID: 12628045 No abstract available.
Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study.
Tanaka Y, Hino M, Gemma A. Tanaka Y, et al. BMC Pulm Med. 2017 Dec 13;17(1):200. doi: 10.1186/s12890-017-0523-2. BMC Pulm Med. 2017. PMID: 29237441 Free PMC article. Clinical Trial.
[Pulmonary arterial hypertension. Therapy with the endothelin-1 receptor antagonist bosentan].
Musch A. Musch A. Med Monatsschr Pharm. 2006 Jul;29(7):242-5. Med Monatsschr Pharm. 2006. PMID: 16866076 Review. German.
Bosentan: a dual endothelin receptor antagonist.
Rubin LJ, Roux S. Rubin LJ, et al. Expert Opin Investig Drugs. 2002 Jul;11(7):991-1002. doi: 10.1517/13543784.11.7.991. Expert Opin Investig Drugs. 2002. PMID: 12084009 Review.

See all similar articles

Cited by

Update in diffuse parenchymal lung disease 2011.
Luckhardt TR, Müller-Quernheim J, Thannickal VJ. Luckhardt TR, et al. Am J Respir Crit Care Med. 2012 Jul 1;186(1):24-9. doi: 10.1164/rccm.201203-0509UP. Am J Respir Crit Care Med. 2012. PMID: 22753686 Free PMC article. Review. No abstract available.
Mechanisms of fibrosis: therapeutic translation for fibrotic disease.
Wynn TA, Ramalingam TR. Wynn TA, et al. Nat Med. 2012 Jul 6;18(7):1028-40. doi: 10.1038/nm.2807. Nat Med. 2012. PMID: 22772564 Free PMC article. Review.
A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
Bauer Y, Tedrow J, de Bernard S, Birker-Robaczewska M, Gibson KF, Guardela BJ, Hess P, Klenk A, Lindell KO, Poirey S, Renault B, Rey M, Weber E, Nayler O, Kaminski N. Bauer Y, et al. Am J Respir Cell Mol Biol. 2015 Feb;52(2):217-31. doi: 10.1165/rcmb.2013-0310OC. Am J Respir Cell Mol Biol. 2015. PMID: 25029475 Free PMC article.
Time to share: lessons from post hoc analyses of IPF trials.
Kass DJ, Kaminski N. Kass DJ, et al. Thorax. 2017 Feb;72(2):101-102. doi: 10.1136/thoraxjnl-2016-209293. Epub 2016 Oct 27. Thorax. 2017. PMID: 27789650 Free PMC article. No abstract available.
Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.
Rosas IO, Dellaripa PF, Lederer DJ, Khanna D, Young LR, Martinez FJ. Rosas IO, et al. Ann Am Thorac Soc. 2014 Apr;11 Suppl 3(Suppl 3):S169-77. doi: 10.1513/AnnalsATS.201312-429LD. Ann Am Thorac Soc. 2014. PMID: 24754826 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.